Pharmaceutical Printer of Inserts, Labels and More

Since 1928, we have been at the forefront of development in the pharmaceutical print industry. Beyond our reputation as the preeminent pharmaceutical printer, we now supply labeling and printing services for medical devices, as well as the bio-tech industry. We are committed to developing and then printing innovative materials that make it easier for you to get vital information to your customers. We do it all through a tried and tested foundation in Current Good Manufacturing Practices (CGMP) and ISO 9001:2015 standards that constantly work to achieve consistency in all of our print processes.

We are proud to boast that Pharmaceutic Litho is one of the few pharmaceutical printers with over 75,000 sq. ft. dedicated solely to pharmaceutical printing. Even so, we continue to grow and expand our secondary packaging services for the pharmaceutical and bio-tech industries in order to build on our reputation as the standard for quality and service in the pharma printing industries.

LATEST NEWS: Pharmaceutic Litho & Label Company Acquires Plymouth Printing

Wilton, CT — Pharmaceutic Litho & Label Company is excited to announce the acquisition of Plymouth Printing Company, Inc. As a current Good Manufacturing Practices (cGMP) compliant specialty printer that exclusively serves the pharmaceutical, biotech and medical device industries... continue reading

Pharmaceutical Printer Products

Inserts & Outserts

Pharmaceutical Inserts Outserts

Pharmaceutical Printing

Pharma Labels

Pharmaceutical Printing

Pharmaceutical Booklets

Pharmaceutical Printing

Pharmaceutical Manuals

Pharmaceutical Printing

years in print

loyal clients

annual orders

printed items each year

Pharmaceutical Printer News

Part of Amgen’s tax savings to go into $300M U.S. biologics plant, 300 new jobs

Amgen designed a biologics manufacturing plant several years ago that was smaller, cheaper and more flexible than the traditional giant-sized, drug-specific model. Then it built it in low-cost Singapore. Now, motivated byRead More…

Posted in Company News | Tagged , | Leave a comment

Gilead Sciences and Kite To Acquire Cell Design Labs

Gilead Sciences, Inc. and its cell therapy subsidiary Kite have entered into a definitive agreement to acquire Cell Design Labs, Inc., gaining new technology platforms that will enhance research and development efforts in cellularRead More…

Posted in Biomedical News | Leave a comment

Amgen, Biocartis sign RAS companion diagnostic deal

Amgen has signed up to help Biocartis get its RAS biomarker tests approved in the U.S. The pact positions Biocartis to register its Idylla RAS tests as companion diagnostics for Amgen’s colorectalRead More…

Posted in Biopharmaceutical | Leave a comment

Missed What You Were Looking For? Below Are The Most Popular Inquiries